Lost Password? No account yet? Register
New Media Advertisement

TOP BUSINESS NEWS

Antares Pharma has recently announced that it has licensed to Pfizer Inc.’s Consumer Healthcare Business Unit one of its drug delivery technologies to develop an undisclosed product on an exclusive basis for North America. The companies did not disclose specifics of the deal.

Readmore

More in: Top Business News

EVENTS

More in: International, National, Domestic

    BIOTECHNOLOGY

    News image

    Bangalore-based biopharmaceutical start-up Biovel Lifesciences is looking to exit from the life sciences space and is keen for an early outright buyout. Biovel has been in dialogue with several companies including Ranbaxy, Avesthagen, Shantha Biotechnics Ltd and Orchid Chemicals, it is learnt.

    Readmore

    More in: Biotechnology

    DEAL WATCH

    News image

    Ahmedabad based Contract Research and Manufacturing Services (CRAMS) major Dishman Pharmaceuticals and Chemicals Ltd has entered into a strategic alliance with California based biotechnology firm Codexis, Inc. that will allow Dishman to use of Codexis' proprietary enzymatic biocatalysis technology to manufacture intermediates and active pharmaceutical...

    Readmore

    More in: Deal Watch

    INDIAN PHARMA INDUSTRY

       [English] [French] [Spanish]

       [English] [French] [Spanish]

    COMPANY PROFILES

    1.Indian Institute of Toxicology - Indian Institute of Toxicology (IIT) is one of the pioneers, independent Contract Research Organization (CRO) engaged in toxicology and has been in the business for the past 25 Years. The institute is committed to excellence, which is borne out of a State-of-art infrastructure & technical skills in the field of Toxicology Studies.... [English]-[French]-[Spanish]

    EMERGING MARKETS

    News image

    The collapse of the property market has left the economy with a huge hole that will be difficult to fill. One of the few sectors that offers hope of growth is the pharmaceutical industry, with senior executives convinced that genuine opportunities remain for Ireland Inc....

    Readmore

    More in: Emerging Markets

    PRODUCTS

    News image

    Pharma major Ranbaxy Laboratories today said it has launched a new dermatological product Lulifin in the Indian market. This follows a strategic in-licensing agreement with Summit Pharmaceuticals International Corporation, Japan, Ranbaxy said.

    Readmore

    More in: Products

    FEATURED ARTICLES

    • Indian Pharma companies eye highIndian Pharma Companies Eye High Potency API Market Pie
      The Indian Active Pharmaceutical Ingredient (API) Industry is fast developing though many challenges exist as it....[English]-[French]-[Spanish]
    • BiogenericsIndian Biogenerics Firms Poised to Storm Western Markets
      With blockbuster first-generation biotherapeutics developed in the West are losing patent protection, Indian biopharma...[English] [French] [Spanish]

    CLINICAL TRIALS

    A new study has been found by The University of Texas Health Science Center at San Antonio that Bat plant, or Tacca chantrieri, could be used to fight cancer.

    Readmore

    More in: Clinical Trials

    HEALTH CARE WATCH

    News image

    Franchise India Holdings limited in association with Francorp and Medium Healthcare Consulting Pvt Ltd has organized a two day workshop on Business of Healthcare, Wellness and Beauty at Taj Lands End, Mumbai. On the occasion India’s First Healthcare, Wellness and Beauty Franchising Report was launched...

    Readmore

    More in: Doctors Speak, Health Insights

    FDA

    News image

    Dishman Pharmaceuticals & Chemicals Ltd, a contract research & manufacturing services (CRAM) major, received the US Food and Drug Administration (USFDA) nod for producing Active Pharmaceutical Ingredients (API) at its Naroda facility here.

    Readmore

    More in: India State Wise, International

    IIT
    pharmaquest-ezine-logo
    Letters and responses
    Exim Bank